Retrospective study to describe prevalence of hyperkalemia in Russian population based on large laboratory network (HEKATE)

Trial Identifier: D1843R00280
Sponsor: AstraZeneca
NCTID:: NCT03657875
Start Date: September 2017
Primary Completion Date: September 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Moscow, Russia